Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

Schilling WHK., Jittamala P., Wongnak P., Watson JA., Boyd S., Luvira V., Siripoon T., Ngamprasertchai T., Batty EM., Beer E., Singh S., Asawasriworanan T., Seers T., Phommasone K., Evans TJ., Kruabkontho V., Ngernseng T., Tubprasert J., Abdad MY., Madmanee W., Kouhathong J., Suwannasin K., Pagornrat W., Piteekan T., Hanboonkunupakarn B., Poovorawan K., Potaporn M., Srisubat A., Loharjun B., Chotivanich K., Imwong M., Pukrittayakamee S., Dondorp AM., Day NPJ., Piyaphanee W., Phumratanaprapin W., White NJ.

DOI

10.1016/s1473-3099(25)00482-7

Type

Journal article

Publisher

Elsevier BV

Publication Date

2026-02-01T00:00:00+00:00

Volume

26

Pages

139 - 147

Total pages

8

Permalink More information Close